Drug intelligence / Profile preview

St. John's wort + kava

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

St. John's wort + kava is a combination of two herbal supplements—St. John's wort (Hypericum perforatum) and kava (Piper methysticum)—used primarily for mood disorders such as depression and anxiety. St. John's wort is known for its antidepressant effects, attributed to active constituents like hypericin and hyperforin, which inhibit the reuptake of neurotransmitters including serotonin, norepinephrine, and dopamine[2][3]. Kava contains kavalactones that exert anxiolytic effects mainly through modulation of GABAergic activity in the central nervous system[2][3]. The combination has been studied in at least one randomized controlled trial for major depressive disorder with comorbid anxiety; results showed some evidence of antidepressant effect but not significant anxiolysis[1][7]. Both herbs have notable potential for drug interactions due to their influence on cytochrome P450 enzymes and other pharmacodynamic pathways[2][6].

Other names
Hypericum perforatum + Piper methysticumSJW + kavaSt. John's wort and kava
02

Targets

DAT (Dopamine plasma membrane transport protein)GABAA (Gamma-aminobutyric acid receptor)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on St. John's wort + kava.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on St. John's wort + kava.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call